← Back to Intel
Insider ActivityELVN
Collins Helen Louise, CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc., sold $117K of ELVN
Updated Jun 13, 2026
Collins Helen Louise
CHIEF MEDICAL OFFICER
Enliven Therapeutics, Inc. ·
$ELVN
Transaction Details
| Insider | Collins Helen Louise |
|---|---|
| Title | CHIEF MEDICAL OFFICER |
| Company | Enliven Therapeutics, Inc. |
| Ticker | ELVN |
| Transaction Type | Sale |
| Transaction Date | 2026-04-17 |
| Shares Traded | 2,441 |
| Price Per Share | $48.0555 |
| Total Value | $117K |
| Filed Date | 2026-04-21 |
| Accession Number | 0001701247-26-000006 |
Ownership Context
| Shares Owned After Transaction | 25,000 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001701247-26-000006
Other Insider Trades — ELVN
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Kunkel Lori Anne | Insider | sold | $267K | 2026-06-05 |
| Kunkel Lori Anne | Insider | sold | $13K | 2026-06-05 |
| Kunkel Lori Anne | Insider | sold | $66K | 2026-06-05 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $137K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | traded | $12K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $52K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $9K | 2026-05-18 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | traded | $12K | 2026-04-17 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $115K | 2026-04-17 |
| Collins Helen Louise | CHIEF MEDICAL OFFICER | sold | $6K | 2026-04-17 |
Other Trades by Collins Helen Louise
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| KURA | Kura Oncology, Inc. | traded | — | 2026-06-04 |
| ELVN | Enliven Therapeutics, Inc. | traded | $12K | 2026-05-18 |
| ELVN | Enliven Therapeutics, Inc. | sold | $137K | 2026-05-18 |
| ELVN | Enliven Therapeutics, Inc. | sold | $52K | 2026-05-18 |
| ELVN | Enliven Therapeutics, Inc. | sold | $9K | 2026-05-18 |
| ELVN | Enliven Therapeutics, Inc. | traded | $12K | 2026-04-17 |
| ELVN | Enliven Therapeutics, Inc. | sold | $6K | 2026-04-17 |
| ELVN | Enliven Therapeutics, Inc. | sold | $115K | 2026-04-17 |
| ELVN | Enliven Therapeutics, Inc. | traded | $99K | 2026-03-25 |
| ELVN | Enliven Therapeutics, Inc. | sold | $1.4M | 2026-03-25 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ELVN — Enliven Therapeutics, Inc. →
Whisper Score — ELVN
50.0
Active Discussion
Current Whisper Score
Track ELVN insider activity in real time on The Wire →
Get alerts when Collins Helen Louise files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 13, 2026 at 07:16 UTC